Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin

Cancer Research

Volumn 62, Issue 21, 2002, Pages 6312-6317

  Kim, Chan Woo ^a   Lee, Hwan Myung ^a   Lee, Tae Hoon ^a   Kang, Chulhun ^a   Kleinman, Hynda K ^b   Gho, Yong Song ^a  

^a Kyung Hee University   (South Korea)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; SPHINGOMYELIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MEMBRANE VESICLE; METASTASIS; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION;

CELL DIVISION; CELL MEMBRANE; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FIBROSARCOMA; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; SPHINGOMYELINS;

EID: 0036830046     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Combes, V., Simon, A. C., Grau, G. E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., and Dignat-George, F. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Investig., 104: 93-102, 1999.
2. Barry, O. P., Pratico, D., Lawson, J. A., and FitzGerald, G. A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Investig., 99: 2118-2127, 1997.
3. Mackenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., and Surprenant, A. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity, 15: 825-835, 2001.
4. Taylor, D. D., and Black, P. H. Shedding of plasma membrane fragments. In: M. Steinberg (ed.), Developmental Biology, pp. 33-57. New York: Plenum, 1986.
5. Cassara, D., Ginestra, A., Dolo, V., Miele, M., Caruso, G., Lucania, G., and Vittorelli, M. L. Modulation of vesicle shedding in 8701 BC human breast carcinoma cells. J. Submicrosc. Cytol. Pathol. 30: 45-53, 1998.
6. Lerner, M. P., Lucid, S. W., Wen, G. J., and Nordquist, R. E. Selected area membrane shedding by tumor cells. Cancer Lett., 20: 125-130, 1983.
7. Van Blitterswijk, W. J., Emmelot, P., Hilkmann, H. A., Hilgers, J., and Feltkamp, C. A. Rigid plasma-membrane-derived vesicles, enriched in tumour-associated surface antigens (MLr), occurring in the ascites fluid of a murine leukaemia (GRSL). Int. J. Cancer. 23: 62-70, 1979.
8. Van Blitterswijk, W. J., De Veer, G., Krol, J. H., and Emmelot, P. Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukemic GRSL cells. Biochim. Biophys. Acta, 688: 495-504, 1982.
9. Alexander, P. Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells? Cancer Res., 34: 2077-2082, 1974.
10. Poutsiaka, D. D., Taylor, D. D., Levy, E. M., and Black, P. H. Inhibition of recombinant interferon-γ-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles. J. Immunol., 134: 145-150, 1985.
11. 3H-thymidine incorporation, are neutralised by anti TGF-β antibodies. J. Submicrosc. Cytol. Pathol., 27: 535-541, 1995.
12. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S., and Zitvogel, L. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med., 7: 297-303, 2001.
13. Ginestra, A., Miceli, D., Dolo, V., Romano, F. M., and Vittorelli, M. L. Membrane vesicles in ovarian cancer fluids: A new potential marker. Anticancer Res., 19: 3439-3445, 1999.
14. Dolo, V., D’Ascenzo, S., Violini, S., Pompucci, L., Festuccia, C., Ginestra, A., Vittorelli, M. L., Canevari, S., and Pavan, A. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis, 17: 131-140, 1999.
15. Ginestra, A., La Placa, M. D., Saladino, F., Cassara, D., Nagase, H., and Vittorelli, M. L. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res., 18: 3433-3437, 1998.
16. Dolo, V., Ginestra, A., Ghersi, G., Nagase, H., and Vittorelli, M. L. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J. Submicrosc. Cytol. Pathol., 26: 173-180, 1994.
17. Ginestra, A., Monea, S., Seghezzi, G., Dolo, V., Nagase, H., Mignatti, P., and Vittorelli, M. L. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem., 272: 17216-17222, 1997.
18. Dolo, V., Ginestra, A., Cassara, D., Violini, S., Lucania, G., Torrisi, M. R., Nagase, H., Canevari, S., Pavan, A., and Vittorelli, M. L. Selective localization of matrix metalloproteinase 9, β1 integrins and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res., 58: 4468-4474, 1998.
19. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. (Bethesda), 82: 4-6, 1990.
20. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
21. Gho, Y. S., Kleinman, H. K., and Sosne, G. Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res., 59: 5128-5132, 1999.
22. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
23. Wu, C., Butz, S., Ying, Y., and Anderson, R. G. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J. Biol. Chem., 272: 3554-3559, 1997.
24. Folch, J., Lees, M., and Sloane Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226: 497-509, 1957.
25. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of the S1KVAV site of laminin in promotion of angiogenesis and tumor growth: An in vivo Matrigel model. J. Natl. Cancer Inst. (Bethesda), 84: 1633-1638, 1992.
26. Bretscher, M. S. Membrane structure: Some general principles. Science (Wash. DC), 181: 622-629, 1973.
27. Dahiya, R., Boyle, B., Goldberg, B. C., Yoon, W. H., Konety, B., Chen, K., Yen, T. S., Blumenfeld, W., and Narayan, P. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem. Cell Biol., 70: 548-554, 1992.
28. Goetzl, E. J., Dolezalova, H., Kong, Y., and Zeng, L. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. Cancer Res., 59: 4732-4737, 1999.
29. Alessenko, A. V. The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death. Membr. Cell Biol., 13: 303-320, 2000.
30. Goetzl, E, J., Kong, Y., and Mei, B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J. Immunol., 162: 2049-2056, 1999.
31. Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., and Spiegel, S. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility, Science (Wash. DC), 291: 1800-1803, 2001.
32. English, D., Welch, Z., Kovala, A. T., Harvey, K., Volpert, O. V., Brindley, D. N., and Garcia, J. G. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J., 14: 2255-2265, 2000.
33. 1-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem., 274: 35343-35350, 1999.
34. Lee, O. H., Kim, Y. M., Lee, Y. M., Moon, E. J., Lee, D. J., Kim, J. H., Kim, K. W., and Kwon, Y. G, Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 264: 743-750, 1999.
35. Boguslawski, G., Lyons, D., Harvey, K. A., Kovala, A. T., and English, D. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem, Biophys. Res, Commun., 272: 603-609, 2000.
36. De Cristan, G., Morbidelli, L., Alessandri, G., Ziche, M., Cappa, A. P., and Gullino, P. M. Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. J. Cell. Physiol., 144: 505-510, 1990.
37. Taraboletti, G., D’Ascenzo, S., Borsotti, P., Giavazzi, R., Pavan, A., and Dolo, V. Shedding of the matrix metalloproteinases MMP-2. MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells, Am. J. Pathol., 160: 673-680, 2002.
38. Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., and Jain, R. K. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med., 2: 992-997, 1996.
39. Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.), 376: 517-519, 1995.
40. Gho, Y. S., Kim, P. N., Li, H. C., Elkin, M., and Kleinman, H. K. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res., 61: 4253-4257, 2001.